Synergy CHC (SNYR) Stock: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$0.09
-0.18 (-67.02%)
βΌ
5d:
-16.2%
30d:
-16.28%
90d:
-56.64%
WAIT
LOW Confidence
Analysis Updated: Sep 17, 2026 12:00 AM ET
Earnings: Sep 17, 2026
0d
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: SNYR is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: SNYR is down 16.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $0.09, which is considered fair relative to its 30-day fair value range of $0.07 to $0.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.6) compared to its historical average (2.9). Remarkably, the market is currently pricing in an annual earnings decline of 40.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $0.64. Short-term momentum is weak, with the stock down 67.0% recently.
Market Sentiment: SNYR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.75 (+4043.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $0.64. Short-term momentum is weak, with the stock down 67.0% recently.
Market Sentiment: SNYR scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.75 (+4043.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.07 -
$0.15
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
45.2%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-67.0%)
- BULLISH: Trading 4043.6% below Wall St target ($3.75)
- WARNING: Composite score 33/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.07 -
$0.15
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.07
Resistance Level
$0.64
Current Trend
Strong Downtrend
Technical data as of
Sep 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.60
Wall Street Target
$3.75
(+4043.6%)
Revenue Growth (YoY)
-32.8%
Earnings Growth (YoY)
-90.6%
Profit Margin
-57.0%
Valuation Discount vs History
-40.8% cheaper
PE vs Historical
0.6 vs 2.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-40.8%
(market-implied from PE analysis)
1-Year Target
$0.08
(-10%)
2-Year Target
$0.07
(-19%)
3-Year Target
$0.07
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1β3)
$0.32
(+250%)
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.6 to 2.9
Stabilization Target:
$0.44
(+380.7%)
PE Expansion Potential:
+380.7%
Share & Embed Analysis
Last updated: October 04, 2026 4:01 AM ET
Data refreshes hourly during market hours. Next update: 5:01 AM
Data refreshes hourly during market hours. Next update: 5:01 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$979 | 64 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$270 | 70 BUY |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$369 | 62 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$97 | 56 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |